<TABLE>
Drug  Name  (Brand Name)                     Biomarker(s)                    Indication(s)
Oncology  (cont.)
74      Exemestane   (Aromasin®)                     ESR1; PGR                       Breast cancer
75      5-Fluorouracil (5-FU) (Efudex®)              DPYD                            Multiple cancers
76      Fulvestrant (Faslodex®)                      ESR1; PGR                       Breast cancer
77      Gefitinib (Iressa®)                          EGFR                            Non-small  cell lung cancer
78      Imatinib (Gleevec®)                          BCR-ABL;   PDGFRB;  KIT;        Multiple cancers,
                                                     FIP1L1-PDGFRA                   myelodysplastic syndrome
79      Irinotecan (Camptosar®)                      UGT1A1                          Colon  cancer, small cell lung
                                                                                     cancer
80      Lapatinib (Tykerb®)                          ERBB2;  HLA-DQA1;               Breast cancer
                                                     HLA-DRB1
81      Lenalidomide  (Revlimid®)                    Del (5q)                        Multiple myeloma,  mantle cell
                                                                                     lymphoma,   myelodysplastic
                                                                                     syndrome
82      Letrozole (Femara®)                          ESR1; PGR                       Breast cancer
83      Mercaptopurine   (Purinethol®)               TPMT                            Acute  lymphocytic leukemia,
                                                                                     chronic myeloid leukemia,
                                                                                     Crohn's disease, and ulcerative
                                                                                     colitis
84      Nilotinib (Tasigna®)                         UGT1A1;  BCR-ABL1               Chronic  myelogenous  leukemia
85      Obinutuzumab   (Gazyva®)                     MS4A1                           Chronic  lymphocytic leukemia,
                                                                                     follicular lymphoma
86      Omacetaxine   mepesuccinate  (Synribo®)      BCR-ABL1                        Chronic  myeloid leukemia
87      Panitumumab   (Vectibix®)                    EGFR;  KRAS                     Colon  cancer
88      Pemetrexed   (Alimta®)                       TS                              Lung  cancer
89      Pertuzumab   (Perjeta®)                      ERBB2                           Breast cancer
Platinum Therapies
90      Carboplatin                                  ERCC1                           Ovarian cancer
91      Cisplatin                                    TPMT                            Multiple cancers
92      Oxaliplatin                                  ERCC1                           Colorectal cancer
93      Nedaplatin                                   ERCC1                           Multiple cancers
94      Triplatin tetranitrate                       ERCC1                           Multiple cancers
95      Satraplatin                                  ERCC1                           Multiple cancers
</TABLE>
<PAGE_HEADER>
Appendix 60
</PAGE_HEADER>
<PAGE_BREAK>
